Trisullak 3A Tablet

LDI's Trimethoprim, Sulfadiazine and Tylosin combination, sold as both a tablet and a water-soluble powder for respiratory and systemic infections in poultry. No withdrawal period is published.

BrandLDI
ManufacturerLakpue Drug, Inc.
TypeAntibiotics
Formtablet, water-soluble
Active ingredientsTrimethoprim (tablet, per tablet) — 80 mg; Sulfadiazine (as Sodium) (tablet, per tablet) — 400 mg; Tylosin (as Tartrate) (tablet, per tablet) — 50 mg; Sodium Sulfadiazine (powder, per gram) — 200 mg; Trimethoprim (powder, per gram) — 400 mg
Label indicationTablet: treatment and control of systemic and respiratory infections like Chronic Respiratory Disease (CRD), Colibacillosis, Fowl Cholera, Salmonella Pullorum and Infectious Coryza. Powder: prevention and treatment of Fowl Cholera, Fowl Typhoid, Salmonellosis, Mastitis, Metritis, Agalactiae, Pneumonia and Dysentery
Withdrawal periodNot published by the manufacturer — ask your veterinarian or agrivet
StatusNot confirmed

We could not confirm this product's withdrawal period against the manufacturer, and we have not estimated one. Do not assume there is none. Ask your veterinarian or agrivet how long to wait before eating the eggs or the bird.

Trisullak 3A Tablet is LDI’s antibacterial line, with a tablet built on Trimethoprim, Sulfadiazine and Tylosin and a separate powder built on Trimethoprim and Sulfadiazine.

What Is Actually In It

The tablet and the powder carry different combinations. Per tablet, LDI lists 80 mg of Trimethoprim, 400 mg of Sulfadiazine (as the sodium salt), and 50 mg of Tylosin (as the tartrate salt). Per gram of powder, LDI lists 200 mg of Sodium Sulfadiazine and 400 mg of Trimethoprim, with no Tylosin. All three named compounds are antibacterials: Tylosin is a macrolide, and Trimethoprim paired with a sulfonamide like Sulfadiazine is a classic potentiated-sulfa combination. These figures are transcribed exactly as LDI states them, with no conversion or rounding.

What the Label Says It Is For

LDI’s label indicates the tablet for treatment and control of systemic and respiratory infections including Chronic Respiratory Disease (CRD), Colibacillosis, Fowl Cholera, Salmonella Pullorum and Infectious Coryza. The powder is indicated separately for prevention and treatment of Fowl Cholera, Fowl Typhoid, Salmonellosis, Mastitis, Metritis, Agalactiae, Pneumonia and Dysentery. Both lists are the manufacturer’s own, reproduced above in the fact table.

Forms It Comes In

Trisullak 3A is sold as a tablet and as a water-soluble powder, each with its own dosing schedule, including separate powder figures for prevention and for treatment. LDI’s full instructions are quoted verbatim in the dosage box above; this body text does not repeat, convert, or adjust any of those figures.

Withdrawal Period

LDI does not publish a withdrawal period for Trisullak 3A. Absence of a published figure is not the same as a zero-day withdrawal, and it is not treated as one here.

What This Page Does Not Tell You

This page transcribes what LDI publishes about Trisullak 3A. It does not tell a reader whether a bird’s symptoms match CRD, Fowl Cholera, or any of the other conditions on the label; several of those diseases produce overlapping symptoms that even an experienced keeper cannot reliably tell apart by eye. Take the bird’s symptoms to a veterinarian, an agrivet, or the local agriculture office before deciding on treatment.

Frequently Asked Questions

What is in Trisullak 3A?

The tablet contains Trimethoprim, Sulfadiazine and Tylosin. The powder contains Trimethoprim and Sodium Sulfadiazine, with no Tylosin.

What is Trisullak 3A used for?

LDI's label lists respiratory and systemic infections for the tablet, and a separate, longer list of enteric and reproductive-tract infections for the powder.

How long is the withdrawal period for Trisullak 3A?

LDI does not publish one.